Emmessar Biotech & Nutrition Ltd — Important, 04-09-2026: Company Update

The company has announced a board meeting to consider and approve the financial results for the quarter and half-year. The board will also discuss a proposal to raise funds by issuing equity shares or other convertible securities on a preferential basis. This fundraising plan requires shareholder approval at an Extra-ordinary General Meeting. This indicates the company is exploring capital-raising options, a key development for investors regarding its future financial structure.